
The 5% Market Share Mystery: The Tale of the Surgeon’s Journey
May 11, 2026
Practical Strategic Reasons For Manufacturers Licensing A Medical Patent
May 18, 2026Medical Patents Broker Inc.
By Kenneth Pearce, President
The Double Indemnity Medical Invention
Imagine a body wrap—a sophisticated sleeve designed to apply variable pressures and temperatures to a limb. This single invention can offer the owner two distinct bites of the apple.
- The Primary Invention (General Wellness): A pressure wrap safe for human use to address common aches, pains, and the general stiffness of injury and old age.
- The Secondary Invention (Medical): The same wrap but enhanced with sensors and electronics to measure vitals (BP, heart rate, temperature, etc.) and programmed to generate specific pulsations to prevent deep vein thrombosis (DVT) and blood clots.
The General Wellness Exemption
- The Strategy: By focusing on fitness, relaxation, and minor “aches and pains,” the primary invention falls under Enforcement Discretion.
- The Speed: You bypass the 510(k) queue entirely. The wrap can be launched as soon as manufacturing is validated. This can generate immediate cash flow.
The Special 510(k) (The 30-Day Sprint)
If the Second Invention (Medical version) is sufficiently similar to an existing predicate—such as a standard pneumatic compression sleeve—the FDA’s goal is a 30-day turnaround. This only works if “fundamental scientific technology” is not changed, and the efficiency is equal to or slightly better than the predicate.
The Standard 510(k)
The Standard 510(k) requires proof of “Substantial Equivalence.” If your secondary invention adds electronic and remote control features, the FDA will look closely at cybersecurity and electromagnetic compatibility (EMC). Proof that the sensors are as accurate as the “gold standard” hospital monitors is required. It is a rigorous process of documentation, but it can secure your place in the clinical as well as residential settings.
The Class III PMA
If you add complex “closed-loop” algorithms—where the wrap automatically changes pressure based on a heart rate spike without human intervention—the FDA may elevate the wrap to Class III. This requires Premarket Approval (PMA) supported by a full clinical trial. A Class III designation could be a game-changer, but for a device that is also a general wellness invention, the disrupter possibility is highly improbable.
The President’s Viewpoint
The Advantages: The “Wellness” version can provide some “fuel” for the FDA journey. It establishes the brand and proves manufacturing reliability while you pursue anticipated higher-value medical clearances.
The Disadvantages: To avoid the legal trap, file the patent application for the medical device before publicly disclosing the “Wellness” version. Not doing this could cause lost revenue because no patent could be granted. Without the medical patent foundation—clearly distinguishing the clot-prevention electronics from the simple heating wrap—the invention becomes much harder to license or sell.




